Cover Image
Read Now

Aspirin for the primary prevention of cardiovascular events a systematic evidence review for the U.S. Preventive Services Task Force

Aspirin reduces the risk of major CVD events (total MI, total stroke, CVD mortality) by 11 percent (relative risk [RR], 0.89 [95% confidence interval (CI), 0.84 to 0.95]), which appears to be largely driven by a 20 percent reduction in nonfatal MI/coronary events (RR, 0.80 [95% CI, 0.72 to 0.88]). A...

Full description

Bibliographic Details
Main Author: Guirguis-Blake, Janelle
Corporate Authors: United States Agency for Healthcare Research and Quality, U.S. Preventive Services Task Force, Oregon Evidence-based Practice Center (Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region))
Format: eBook
Language:English
Published: Rockville, MD Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [2015], 2015
Series:Evidence synthesis
Subjects:
United States
Randomized Controlled Trials As Topic
Primary Prevention
Cardiovascular Diseases / Drug Therapy
Cardiovascular Diseases / Prevention & Control
Aspirin / Adverse Effects
Aspirin / Therapeutic Use
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Table of Contents:
  • Includes bibliographical references

Similar Items